KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Return on Sales (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Return on Sales for 6 consecutive years, with 0.0% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales changed 0.0% year-over-year to 0.0%, compared with a TTM value of 0.0% through Sep 2025, changed 0.0%, and an annual FY2024 reading of 0.0%, up 13.0% over the prior year.
  • Return on Sales was 0.0% for Q3 2025 at Clover Health Investments, up from 0.0% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.01% in Q1 2023 and bottomed at 0.73% in Q3 2021.
  • Average Return on Sales over 5 years is 0.15%, with a median of 0.04% recorded in 2023.
  • The sharpest move saw Return on Sales tumbled -72bps in 2021, then skyrocketed 68bps in 2022.
  • Year by year, Return on Sales stood at 0.29% in 2021, then soared by 58bps to 0.12% in 2022, then soared by 69bps to 0.04% in 2023, then skyrocketed by 95bps to 0.0% in 2024, then surged by 81bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for CLOV at 0.0% in Q3 2025, 0.0% in Q2 2025, and 0.0% in Q1 2025.